These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 11421607)
1. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma. Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607 [TBL] [Abstract][Full Text] [Related]
2. Expression of telomerase genes in thyroid carcinoma. Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma. Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569 [TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763 [TBL] [Abstract][Full Text] [Related]
5. Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions. Amioka T; Kitadai Y; Hiyama T; Tanaka S; Yoshihara M; Haruma K; Chayama K Oncol Rep; 2004 Jan; 11(1):51-5. PubMed ID: 14654902 [TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT). Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A Anticancer Res; 2005; 25(1B):509-14. PubMed ID: 15816620 [TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues. Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675 [TBL] [Abstract][Full Text] [Related]
8. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma. Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959 [TBL] [Abstract][Full Text] [Related]
10. Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T Mod Pathol; 2001 Nov; 14(11):1073-8. PubMed ID: 11706066 [TBL] [Abstract][Full Text] [Related]
11. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825 [TBL] [Abstract][Full Text] [Related]
12. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250 [TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Saji M; Xydas S; Westra WH; Liang CK; Clark DP; Udelsman R; Umbricht CB; Sukumar S; Zeiger MA Clin Cancer Res; 1999 Jun; 5(6):1483-9. PubMed ID: 10389936 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy. Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498 [TBL] [Abstract][Full Text] [Related]
16. Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ. Kim HR; Christensen R; Park NH; Sapp P; Kang MK; Park NH Clin Cancer Res; 2001 Oct; 7(10):3079-86. PubMed ID: 11595698 [TBL] [Abstract][Full Text] [Related]
17. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042 [TBL] [Abstract][Full Text] [Related]
18. Telomerase and c-myc expression in hepatocellular carcinomas. Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891 [TBL] [Abstract][Full Text] [Related]
19. Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma. Fukushima M; Shimomura N; Nakamura K; Kammori M; Koizumi K; Shimizu K; Takubo K Oncol Rep; 2004 Dec; 12(6):1227-32. PubMed ID: 15547742 [TBL] [Abstract][Full Text] [Related]
20. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]